Home/Filings/4/0001179110-18-001910
4//SEC Filing

NEWTON ROGER S 4

Accession 0001179110-18-001910

CIK 0001434868other

Filed

Feb 8, 7:00 PM ET

Accepted

Feb 9, 5:47 PM ET

Size

9.4 KB

Accession

0001179110-18-001910

Insider Transaction Report

Form 4
Period: 2018-02-07
NEWTON ROGER S
DirectorExecutive Chairman, CSO
Transactions
  • Gift

    Common Stock

    2017-12-1212,000617,683 total
  • Exercise/Conversion

    Common Stock

    2018-02-07$6.99/sh+34,651$242,210652,334 total
  • Tax Payment

    Common Stock

    2018-02-07$6.99/sh3,608$25,220648,726 total
  • Exercise/Conversion

    Warrant to Purchase Common Stock

    2018-02-0734,6510 total
    Exercise: $6.99Exp: 2018-02-12Common Stock (34,651 underlying)
Footnotes (1)
  • [F1]Fully exercisable as of the date hereof.

Issuer

Esperion Therapeutics, Inc.

CIK 0001434868

Entity typeother

Related Parties

1
  • filerCIK 0001242612

Filing Metadata

Form type
4
Filed
Feb 8, 7:00 PM ET
Accepted
Feb 9, 5:47 PM ET
Size
9.4 KB